Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Galmed Pharmaceuticals acquires Colospan Ltd.

PUBLIC · GLMDSep 09, 2026about 3 hours ago

Acquiring Company

Galmed Pharmaceuticals Ltd

Acquired Company

Colospan Ltd

Tel Aviv DistrictRaipurBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

Galmed Pharmaceuticals Ltd. has acquired Colospan Ltd., expanding its focus to include a medical device platform complementing its biopharmaceutical activities. This acquisition is part of Galmed's strategy to develop innovative therapies addressing unmet medical needs in gastrointestinal diseases. Following the acquisition, Galmed has rebranded itself as Eocene Ltd. to reflect its new direction. The company's website has also been updated to support its new identity.

Company Information

Company

Galmed Pharmaceuticals Ltd

Location

Tel Aviv District, Israel

About

Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing innovative therapies for liver diseases and other conditions. The company's expertise spans drug development and corporate management, enhancing its capabilities in the healthcare sector. Galmed is listed on the NASDAQ and is committed to addressing unmet medical needs through its research and development efforts.

Don't miss Galmed Pharmaceuticals Ltd's next move

Get an email the moment Galmed Pharmaceuticals Ltd makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Yohai
Senior decision-maker at this company
••••••••@••••••••

See Yohai's verified email →

Guy
Senior decision-maker at this company
••••••••@••••••••

See Guy's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Galmed Pharmaceuticals Ltd's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Colospan Ltd?

Colospan Ltd was acquired by Galmed Pharmaceuticals Ltd, based in Tel Aviv District. The deal was reported on September 9, 2026. Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing innovative therapies for liver diseases and other conditions. Galmed Pharmaceuticals Ltd is publicly traded (GLMD) and operates in Biotechnology.

When did Galmed Pharmaceuticals Ltd acquire Colospan Ltd?

Galmed Pharmaceuticals Ltd's acquisition of Colospan Ltd was reported on September 9, 2026. Galmed Pharmaceuticals Ltd. has acquired Colospan Ltd., expanding its focus to include a medical device platform complementing its biopharmaceutical activities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Colospan Ltd do?

Colospan Ltd. is a commercial-stage medical device company specializing in innovative solutions for colorectal surgery complications, particularly addressing anastomotic leaks. It is privately held, operating in Manufacturing, and is based in Raipur.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.